129 related articles for article (PubMed ID: 37831046)
21. Comprehensive Analysis of Stroke in the Long-Term Cohort of the MOMENTUM 3 Study.
Colombo PC; Mehra MR; Goldstein DJ; Estep JD; Salerno C; Jorde UP; Cowger JA; Cleveland JC; Uriel N; Sayer G; Skipper ER; Downey FX; Ono M; Hooker R; Anyanwu AC; Givertz MM; Mahr C; Topuria I; Somo SI; Crandall DL; Horstmanshof DA
Circulation; 2019 Jan; 139(2):155-168. PubMed ID: 30586698
[TBL] [Abstract][Full Text] [Related]
22. Short-Term Outcomes of Magnetically Levitated Left Ventricular Assist Device in Advanced Heart Failure - The Japanese Cohort.
Inoue K; Fujita T; Yoshioka D; Tonai K; Yanagino Y; Kakuta T; Tadokoro N; Kawamoto N; Yamashita K; Kawamura A; Matsuura R; Kawamura T; Saito T; Kawamura M; Kainuma S; Fukushima S; Toda K; Miyagawa S
Circ J; 2022 Nov; 86(12):1961-1967. PubMed ID: 36273915
[TBL] [Abstract][Full Text] [Related]
23. Healthcare Resource Use and Cost Implications in the MOMENTUM 3 Long-Term Outcome Study.
Mehra MR; Salerno C; Cleveland JC; Pinney S; Yuzefpolskaya M; Milano CA; Itoh A; Goldstein DJ; Uriel N; Gulati S; Pagani FD; John R; Adamson R; Bogaev R; Thohan V; Chuang J; Sood P; Goates S; Silvestry SC
Circulation; 2018 Oct; 138(18):1923-1934. PubMed ID: 29807933
[TBL] [Abstract][Full Text] [Related]
24. Incidence and clinical correlates of de-novo aortic regurgitation with a fully magnetically levitated left ventricular assist device: a MOMENTUM 3 trial portfolio analysis.
Uriel N; Milano C; Agarwal R; Lee S; Cleveland J; Goldstein D; Wang A; Crandall D; Mehra MR
Eur J Heart Fail; 2023 Feb; 25(2):286-294. PubMed ID: 36404406
[TBL] [Abstract][Full Text] [Related]
25. Third-generation continuous-flow left ventricular assist devices: a comparative outcome analysis by device type.
Mihalj M; Heinisch PP; Schober P; Wieser M; Martinelli M; de By TMMH; Schefold JC; Luedi MM; Kadner A; Carrel T; Mohacsi P; Hunziker L; Reineke D
ESC Heart Fail; 2022 Oct; 9(5):3469-3482. PubMed ID: 35880515
[TBL] [Abstract][Full Text] [Related]
26. A Fully Magnetically Levitated Circulatory Pump for Advanced Heart Failure.
Mehra MR; Naka Y; Uriel N; Goldstein DJ; Cleveland JC; Colombo PC; Walsh MN; Milano CA; Patel CB; Jorde UP; Pagani FD; Aaronson KD; Dean DA; McCants K; Itoh A; Ewald GA; Horstmanshof D; Long JW; Salerno C;
N Engl J Med; 2017 Feb; 376(5):440-450. PubMed ID: 27959709
[TBL] [Abstract][Full Text] [Related]
27. Aspirin and left ventricular assist devices: rationale and design for the international randomized, placebo-controlled, non-inferiority ARIES HM3 trial.
Mehra MR; Crandall DL; Gustafsson F; Jorde UP; Katz JN; Netuka I; Uriel N; Connors JM; Sood P; Heatley G; Pagani FD
Eur J Heart Fail; 2021 Jul; 23(7):1226-1237. PubMed ID: 34142415
[TBL] [Abstract][Full Text] [Related]
28. Ventricular assist device using a thoracotomy-based implant technique: Multi-Center Implantation of the HeartMate 3 in Subjects With Heart Failure Using Surgical Techniques Other Than Full Median Sternotomy (HM3 SWIFT).
Gosev I; Pham DT; Um JY; Anyanwu AC; Itoh A; Kotkar K; Takeda K; Naka Y; Peltz M; Silvestry SC; Couper G; Leacche M; Rao V; Sun B; Tedford RJ; Mokadam N; McNutt R; Crandall D; Mehra MR; Salerno CT
J Thorac Cardiovasc Surg; 2024 Feb; ():. PubMed ID: 38367698
[TBL] [Abstract][Full Text] [Related]
29. Gender and Race Differences in HeartMate3 Left Ventricular Assist Device as a Bridge to Transplantation.
Steinberg RS; Okoh AK; Wang J; Patel KJ; Gangavelli A; Nayak A; Ko YA; Gupta D; Daneshmand M; Vega JD; Morris AA
JACC Heart Fail; 2023 Dec; ():. PubMed ID: 38180429
[TBL] [Abstract][Full Text] [Related]
30. Impact of age, sex, therapeutic intent, race and severity of advanced heart failure on short-term principal outcomes in the MOMENTUM 3 trial.
Goldstein DJ; Mehra MR; Naka Y; Salerno C; Uriel N; Dean D; Itoh A; Pagani FD; Skipper ER; Bhat G; Raval N; Bruckner BA; Estep JD; Cogswell R; Milano C; Fendelander L; O'Connell JB; Cleveland J;
J Heart Lung Transplant; 2018 Jan; 37(1):7-14. PubMed ID: 29154131
[TBL] [Abstract][Full Text] [Related]
31. Outcomes in Smaller Body Size Adults After HeartMate 3 Left Ventricular Assist Device Implantation.
Molina EJ; Cowger J; Lee S; Horstmanshof D; Cleveland JC; Goldstein DJ; Mehra MR; Uriel N; Salerno CT; Bourque K; Chuang J; Naka Y
Ann Thorac Surg; 2022 Dec; 114(6):2262-2269. PubMed ID: 35452663
[TBL] [Abstract][Full Text] [Related]
32. Implantation of a fully magnetically levitated left ventricular assist device using a sternal-sparing surgical technique.
Gosev I; Wood K; Ayers B; Barrus B; Knight P; Alexis JD; Vidula H; Lander H; Wyrobek J; Cheyne C; Goldenberg I; McNitt S; Prasad S
J Heart Lung Transplant; 2020 Jan; 39(1):37-44. PubMed ID: 31636043
[TBL] [Abstract][Full Text] [Related]
33. Retrospective 1-year outcome follow-up in 200 patients supported with HeartMate 3 and HeartWare left ventricular assist devices in a single centre.
Mueller M; Hoermandinger C; Richter G; Mulzer J; Tsyganenko D; Krabatsch T; Starck C; Stein J; Schoenrath F; Falk V; Potapov E
Eur J Cardiothorac Surg; 2020 Jun; 57(6):1160-1165. PubMed ID: 32298426
[TBL] [Abstract][Full Text] [Related]
34. Do patients with the centrifugal flow HeartMate 3 or HeartWare left ventricular assist device have better outcomes compared to those with axial flow HeartMate II?
Florisson DS; Conte SM; De Bono JA; Newcomb AE
Interact Cardiovasc Thorac Surg; 2019 Dec; 29(6):844-851. PubMed ID: 31436825
[TBL] [Abstract][Full Text] [Related]
35. Six-month outcomes after treatment of advanced heart failure with a full magnetically levitated continuous flow left ventricular assist device: report from the ELEVATE registry.
Gustafsson F; Shaw S; Lavee J; Saeed D; Pya Y; Krabatsch T; Schmitto J; Morshuis M; Chuang J; Damme L; Zimpfer D; Garbade J
Eur Heart J; 2018 Oct; 39(37):3454-3460. PubMed ID: 30165521
[TBL] [Abstract][Full Text] [Related]
36. Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients: The ROADMAP Study 2-Year Results.
Starling RC; Estep JD; Horstmanshof DA; Milano CA; Stehlik J; Shah KB; Bruckner BA; Lee S; Long JW; Selzman CH; Kasirajan V; Haas DC; Boyle AJ; Chuang J; Farrar DJ; Rogers JG;
JACC Heart Fail; 2017 Jul; 5(7):518-527. PubMed ID: 28396040
[TBL] [Abstract][Full Text] [Related]
37. A clinical and cost-effectiveness analysis of the HeartMate 3 left ventricular assist device for transplant-ineligible patients: A United Kingdom perspective.
Lim HS; Shaw S; Carter AW; Jayawardana S; Mossialos E; Mehra MR
J Heart Lung Transplant; 2022 Feb; 41(2):174-186. PubMed ID: 34922821
[TBL] [Abstract][Full Text] [Related]
38. Fully magnetically centrifugal left ventricular assist device and long-term outcomes: the ELEVATE registry.
Schmitto JD; Shaw S; Garbade J; Gustafsson F; Morshuis M; Zimpfer D; Lavee J; Pya Y; Berchtold-Herz M; Wang A; Gazzola C; Potapov E; Saeed D
Eur Heart J; 2024 Feb; 45(8):613-625. PubMed ID: 38036414
[TBL] [Abstract][Full Text] [Related]
39. Adverse events in contemporary continuous-flow left ventricular assist devices: A multi-institutional comparison shows significant differences.
Stulak JM; Davis ME; Haglund N; Dunlay S; Cowger J; Shah P; Pagani FD; Aaronson KD; Maltais S
J Thorac Cardiovasc Surg; 2016 Jan; 151(1):177-89. PubMed ID: 26545967
[TBL] [Abstract][Full Text] [Related]
40. Assessment of Mortality Among Durable Left Ventricular Assist Device Recipients Ineligible for Clinical Trials.
Brescia AA; Watt TMF; Pagani FD; Cascino TM; Zhang M; McCullough JS; Shore S; Likosky DS; Aaronson KD; Thompson MP;
JAMA Netw Open; 2021 Jan; 4(1):e2032865. PubMed ID: 33416886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
